Structure and Function of p53-DNA Complexes with Inactivation and Rescue Mutations: A Molecular Dynamics Simulation Study - PubMed
- ️Thu Jan 01 2015
Structure and Function of p53-DNA Complexes with Inactivation and Rescue Mutations: A Molecular Dynamics Simulation Study
Balu Kamaraj et al. PLoS One. 2015.
Abstract
The tumor suppressor protein p53 can lose its function upon DNA-contact mutations (R273C and R273H) in the core DNA-binding domain. The activity can be restored by second-site suppressor or rescue mutations (R273C_T284R, R273H_T284R, and R273H_S240R). In this paper, we elucidate the structural and functional consequence of p53 proteins upon DNA-contact mutations and rescue mutations and the underlying mechanisms at the atomic level by means of molecular dynamics simulations. Furthermore, we also apply the docking approach to investigate the binding phenomena between the p53 protein and DNA upon DNA-contact mutations and rescue mutations. This study clearly illustrates that, due to DNA-contact mutants, the p53 structure loses its stability and becomes more rigid than the native protein. This structural loss might affect the p53-DNA interaction and leads to inhibition of the cancer suppression. Rescue mutants (R273C_T284R, R273H_T284R and R273H_S240R) can restore the functional activity of the p53 protein upon DNA-contact mutations and show a good interaction between the p53 protein and a DNA molecule, which may lead to reactivate the cancer suppression function. Understanding the effects of p53 cancer and rescue mutations at the molecular level will be helpful for designing drugs for p53 associated cancer diseases. These drugs should be designed so that they can help to inhibit the abnormal function of the p53 protein and to reactivate the p53 function (cell apoptosis) to treat human cancer.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures

(A) Shows the normal p53-DNA interaction, leading to cancer suppression. (B) Illustrates how a DNA-contact mutation results in a reduced p53-DNA affinity, which is a possible cause of cancer. (C) Shows that a rescue mutation can restore the good p53-DNA affinity, and thus give again rise to cancer suppression.

(a) Native, R273C and R273C_T284R, (b) Native, R273H and R273H_T284R, (c) Native, R273H and R273H_S240R.

(a) Native, R273C and R273C_T284R, (b) Native, R273H and R273H_T284R, (c) Native, R273H and R273H_S240R.

(a) Native, R273C and R273C_T284R, (b) Native, R273H and R273H_T284R, (c) Native, R273H and R273H_S240R.

(a) Native, R273C and R273C_T284R, (b) Native, R273H and R273H_T284R, (c) Native, R273H and R273H_S240R.

(a) Native, R273C and R273C_T284R, (b) Native, R273H and R273H_T284R, (c) Native, R273H and R273H_S240R.

(a) Native, R273C and R273C_T284R, (b) Native, R273H and R273H_T284R, (c) Native, R273H and R273H_S240R.

(a) Native-DNA complex, (b) R273C-DNA complex, (c) R273H-DNA complex, (d) R273C_T284R-DNA complex, (e) R273H_T284R-DNA complex and (f) R273H_S240R-DNA complex. The color coding represents the p53 protein in brown color, DNA in purple color. Hydrogen bonding interactions are denoted by dashed lines. This figure was prepared by Ligplot.
Similar articles
-
Mutants TP53 p.R273H and p.R273C but not p.R273G enhance cancer cell malignancy.
Li J, Yang L, Gaur S, Zhang K, Wu X, Yuan YC, Li H, Hu S, Weng Y, Yen Y. Li J, et al. Hum Mutat. 2014 May;35(5):575-84. doi: 10.1002/humu.22528. Epub 2014 Apr 7. Hum Mutat. 2014. PMID: 24677579
-
Suad O, Rozenberg H, Brosh R, Diskin-Posner Y, Kessler N, Shimon LJ, Frolow F, Liran A, Rotter V, Shakked Z. Suad O, et al. J Mol Biol. 2009 Jan 9;385(1):249-65. doi: 10.1016/j.jmb.2008.10.063. Epub 2008 Oct 30. J Mol Biol. 2009. PMID: 18996393
-
Demir Ö, Baronio R, Salehi F, Wassman CD, Hall L, Hatfield GW, Chamberlin R, Kaiser P, Lathrop RH, Amaro RE. Demir Ö, et al. PLoS Comput Biol. 2011 Oct;7(10):e1002238. doi: 10.1371/journal.pcbi.1002238. Epub 2011 Oct 20. PLoS Comput Biol. 2011. PMID: 22028641 Free PMC article.
-
Structural and sequential context of p53: A review of experimental and theoretical evidence.
Saha T, Kar RK, Sa G. Saha T, et al. Prog Biophys Mol Biol. 2015 Mar;117(2-3):250-263. doi: 10.1016/j.pbiomolbio.2014.12.002. Epub 2014 Dec 27. Prog Biophys Mol Biol. 2015. PMID: 25550083 Review.
-
Structure-function-rescue: the diverse nature of common p53 cancer mutants.
Joerger AC, Fersht AR. Joerger AC, et al. Oncogene. 2007 Apr 2;26(15):2226-42. doi: 10.1038/sj.onc.1210291. Oncogene. 2007. PMID: 17401432 Review.
Cited by
-
mCSM-NA: predicting the effects of mutations on protein-nucleic acids interactions.
Pires DEV, Ascher DB. Pires DEV, et al. Nucleic Acids Res. 2017 Jul 3;45(W1):W241-W246. doi: 10.1093/nar/gkx236. Nucleic Acids Res. 2017. PMID: 28383703 Free PMC article.
-
Targeting p53 pathways: mechanisms, structures, and advances in therapy.
Wang H, Guo M, Wei H, Chen Y. Wang H, et al. Signal Transduct Target Ther. 2023 Mar 1;8(1):92. doi: 10.1038/s41392-023-01347-1. Signal Transduct Target Ther. 2023. PMID: 36859359 Free PMC article. Review.
-
Identification of MicroRNAs That Stabilize p53 in Human Papillomavirus-Positive Cancer Cells.
Martínez-Noël G, Szajner P, Kramer RE, Boyland KA, Sheikh A, Smith JA, Howley PM. Martínez-Noël G, et al. J Virol. 2022 Feb 23;96(4):e0186521. doi: 10.1128/JVI.01865-21. Epub 2021 Dec 8. J Virol. 2022. PMID: 34878887 Free PMC article.
-
Alzhanova D, Meyo JO, Juarez A, Dittmer DP. Alzhanova D, et al. J Virol. 2021 Nov 9;95(23):e0145921. doi: 10.1128/JVI.01459-21. Epub 2021 Sep 15. J Virol. 2021. PMID: 34523970 Free PMC article.
-
Bromley D, Daggett V. Bromley D, et al. Protein Sci. 2020 Sep;29(9):1983-1999. doi: 10.1002/pro.3921. Epub 2020 Aug 17. Protein Sci. 2020. PMID: 32715544 Free PMC article.
References
-
- Meulmeester E, Jochemsen AG. p53: a guide to apoptosis. Curr Cancer Drug Targets 2008;8: 87–97. - PubMed
-
- Lim YP, Lim TT, Chan YL, Song AC, Yeo BH, Vojtesek B, et al. The p53 knowledgebase: an integrated information resource for p53 research. Oncogene 2007;26: 1517–1521. - PubMed
-
- Gomez-Lazaro M, Fernandez-Gomez FJ, Jordán J. p53: twenty five years understanding the mechanism of genome protection. J PhysiolBiochem 2004;60: 287–307. - PubMed
-
- Sakaguchi K, Sakamoto H, Xie D, Erickson JW, Lewis MS, Anderson CW et al. Effect of phosphorylation on tetramerization of the tumor suppressor protein p53. J Protein Chem. 1997;16: 553–556. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
This research was financially supported by the Methusalem funding.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous